Post-marketing studies can make important contributions to medical knowledgeBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e4740 (Published 16 July 2012) Cite this as: BMJ 2012;345:e4740
- Martin C Michel, clinical pharmacologist1
- 1Institut für Pharmakologie, Johannes Gutenberg Universität, 55101 Mainz, Germany
My experience in collaborating with various drug companies in the design, execution, analysis, and publication of post-marketing surveillance (PMS) studies differs greatly from that described in your recent article.1 The general consensus was that PMS studies serve a scientific purpose. Studies typically had predefined scientific questions and were powered to answer them. Some studies had been recommended by the regulatory authorities, such …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial